newsfilter
← Latest News
PR Newswire·

BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology

BLLN
  • BillionToOne appointed Allen Chen, MD, MBA, as Vice President of Medical Affairs and Clinical Development, Oncology.
  • Dr. Chen brings over 20 years of experience as a physician-executive & clinician-scientist across major academic medical centers.
  • He previously served in senior leadership roles at UC Davis, UCLA, University of Kansas Cancer Center, & UC Irvine.
  • Dr. Chen holds an MD from Yale, double MBAs from National University of Singapore & UCLA Anderson, & a Bachelor's from Cornell.
  • His career includes serving as principal investigator for dozens of clinical trials & authoring over 300 peer-reviewed publications.
  • In his new role, Dr. Chen will lead medical affairs strategy & clinical research development for the Northstar oncology portfolio.
  • Northstar Select is an 84-gene, single-molecule NGS ctDNA panel for identifying actionable genomic alterations in solid tumors.
  • Northstar Response is a tissue-free, methylation-based assay for monitoring treatment response with single-molecule precision.
  • Gary Palmer, MD, retired as Chief Medical Officer, Oncology, & will continue in a CMO Emeritus Advisory role.
  • Dr. Palmer helped establish the clinical strategy & foundation of the Northstar portfolio during his tenure.
  • BillionToOne is headquartered in Menlo Park, California, & utilizes its patented Quantitative Counting Templates technology.
  • The press release includes standard forward-looking statements regarding the scalability of the company's oncology mission.